cl 218872 has been researched along with brotizolam in 1 studies
| Studies (cl 218872) | Trials (cl 218872) | Recent Studies (post-2010) (cl 218872) | Studies (brotizolam) | Trials (brotizolam) | Recent Studies (post-2010) (brotizolam) |
|---|---|---|---|---|---|
| 158 | 0 | 3 | 169 | 50 | 18 |
| Protein | Taxonomy | cl 218872 (IC50) | brotizolam (IC50) |
|---|---|---|---|
| Platelet-activating factor receptor | Homo sapiens (human) | 0.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirouchi, M; Kohno, Y; Kuriyama, K; Mizutani, H | 1 |
1 other study(ies) available for cl 218872 and brotizolam
| Article | Year |
|---|---|
Characteristics of the association of brotizolam, a thieno-triazolo diazepine derivative, with the benzodiazepine receptor: a selective and high affinity ligand of the central type I benzodiazepine receptor.
Topics: Animals; Anti-Anxiety Agents; Azepines; Brain; Dose-Response Relationship, Drug; Flunitrazepam; Hypnotics and Sedatives; In Vitro Techniques; Nitrazepam; Pyridazines; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, GABA-A; Spinal Cord; Synaptic Membranes; Tritium | 1992 |